Downstream Processing Market is Growing With Promising Value of USD 92.0 Billion by 2030

According to a Allied Market Research, the global Downstream Processing Market was estimated at $21.8 billion in 2020 and is expected to hit $92.0 billion by 2030, registering a CAGR of 13.5% from 2021 to 2030.The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

• The increasing demand for biopharmaceuticals, the growing popularity of single-use technologies, and advancements in bioprocessing and chromatography technologies are driving the growth of the downstream processing market.
• BThe biopharmaceutical segment dominated the downstream processing market in 2020 and is expected to continue to lead the market during the forecast period due to the high demand for biopharmaceutical products.
• The chromatography segment is expected to grow at the highest CAGR during the forecast period due to the increasing adoption of chromatography techniques for the separation and purification of biomolecules.
• North America dominated the downstream processing market in 2020 due to the presence of major biopharmaceutical companies and a well-established healthcare infrastructure. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to the increasing adoption of biopharmaceutical products in the region.

Request Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/2862

Downstream Processing Market Scope:

Market Drivers

• Increasing demand for biopharmaceuticals: The demand for biopharmaceuticals has been increasing rapidly due to their high effectiveness and specificity in treating diseases. Downstream processing plays a crucial role in the production of biopharmaceuticals, which is driving the growth of the market.
• Growing popularity of single-use technologies: Single-use technologies have gained popularity in recent years due to their cost-effectiveness, flexibility, and reduced risk of contamination. Downstream processing is increasingly adopting single-use technologies, which is driving the growth of the market.
• Advancements in bioprocessing and chromatography technologies: There have been significant advancements in bioprocessing and chromatography technologies, which have led to increased efficiency and reduced processing times in downstream processing. These advancements are driving the growth of the market.

Market Segmentation

• Product: The downstream processing market can be segmented by product into chromatography columns and resins, filters, membrane adsorbers, single-use products, evaporators, centrifuges, dryers, and others.
• Technique: The downstream processing market can be segmented by technique into chromatography, filtration, centrifugation, membrane separation, and other techniques.
• Application: The downstream processing market can be segmented by application into monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, enzyme production, and others.
• End-user: The downstream processing market can be segmented by end-user into biopharmaceutical manufacturers, contract research and manufacturing organizations (CROs/CMOs), and academic and research institutes.

Request for Customization

https://www.alliedmarketresearch.com/request-for-customization/2862

Regional Growth Dynamics

The market across North America held the lion’s share in 2020, garnering around two-fifths of the global market. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 14.6% by the end of 2030. The other provinces studied in the report include Europe and LAMEA.

Competitive Landscape

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• GE Healthcare
• Danaher Corporation
• Sartorius Stedim Biotech S.A.
• 3M Company
• Repligen Corporation
• Lonza Group AG
• Eppendorf AG
• Corning Incorporated

Recent developments:

• In January 2022, Avantor, a leading supplier of products and services to the biopharmaceutical industry, announced the acquisition of RIM Bio, a provider of purification solutions for gene therapy manufacturing, which strengthens Avantor’s position in the downstream processing market.
• In September 2022, Pall Corporation launched a new range of chromatography columns, the Cadence BioSMB Process System, which provides a cost-effective and high-throughput solution for the purification of biopharmaceuticals.
• In September 2021, Thermo Fisher Scientific, a leading player in the downstream processing market, announced the launch of a new high-throughput chromatography system, the Thermo Scientific Vanquish Core HPLC System, which is designed to improve laboratory productivity and reduce operating costs.

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/2862

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: 

https://www.alliedmarketresearch.com/connect-to-analyst/2862

Browse more latest healthcare reports:

Skin Biopsy Market by Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy), by Indication (Skin cancer, Actinic keratosis, Dermatitis, Others), by End User (Hospital and Clinics, Diagnostic Laboratories, Other): Global Opportunity Analysis and Industry Forecast, 2021-2031

Dystonia Drugs Market by Drug Type (Dopaminergic agents, GABAergic agents, Anticonvulsants drugs, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com